| Pleiotropic actions of peroxisome proliferator–activated receptors in lipid metabolism and atherosclerosis O Barbier, IP Torra, Y Duguay, C Blanquart, JC Fruchart, C Glineur, ... Arteriosclerosis, thrombosis, and vascular biology 22 (5), 717-726, 2002 | 597 | 2002 |
| Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation C Blanquart, O Barbier, JC Fruchart, B Staels, C Glineur The Journal of steroid biochemistry and molecular biology 85 (2-5), 267-273, 2003 | 423 | 2003 |
| Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression T Claudel, Y Inoue, O Barbier, D Duran-Sandoval, V Kosykh, J Fruchart, ... Gastroenterology 125 (2), 544-555, 2003 | 310 | 2003 |
| Glucose regulates the expression of the farnesoid X receptor in liver D Duran-Sandoval, G Mautino, G Martin, F Percevault, O Barbier, ... Diabetes 53 (4), 890-898, 2004 | 305 | 2004 |
| Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans A Bélanger, G Pelletier, F Labrie, O Barbier, S Chouinard Trends in Endocrinology & Metabolism 14 (10), 473-479, 2003 | 294 | 2003 |
| Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice FF Anhê, RT Nachbar, TV Varin, J Trottier, S Dudonné, M Le Barz, ... Gut 68 (3), 453-464, 2019 | 257 | 2019 |
| FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity O Barbier, IP Torra, A Sirvent, T Claudel, C Blanquart, D Duran-Sandoval, ... Gastroenterology 124 (7), 1926-1940, 2003 | 230 | 2003 |
| PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a F Gizard, C Amant, O Barbier, S Bellosta, R Robillard, F Percevault, ... The Journal of clinical investigation 115 (11), 3228-3238, 2005 | 222 | 2005 |
| 3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7) O Barbier, D Turgeon, C Girard, MD Green, TR Tephly, DW Hum, ... Drug Metabolism and Disposition 28 (5), 497-502, 2000 | 222 | 2000 |
| Acute antiinflammatory properties of statins involve peroxisome proliferator–activated receptor-α via inhibition of the protein kinase C signaling pathway R Paumelle, C Blanquart, O Briand, O Barbier, C Duhem, G Woerly, ... Circulation research 98 (3), 361-369, 2006 | 197 | 2006 |
| Peroxisome proliferator-activated receptor α induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme O Barbier, D Duran-Sandoval, I Pineda-Torra, V Kosykh, JC Fruchart, ... Journal of Biological Chemistry 278 (35), 32852-32860, 2003 | 181 | 2003 |
| Peroxisome proliferator-activated receptor α (PPARα) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes C Blanquart, O Barbier, JC Fruchart, B Staels, C Glineur Journal of Biological Chemistry 277 (40), 37254-37259, 2002 | 178 | 2002 |
| The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor α and γ target gene O Barbier, L Villeneuve, V Bocher, C Fontaine, IP Torra, C Duhem, ... Journal of Biological Chemistry 278 (16), 13975-13983, 2003 | 177 | 2003 |
| Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay L Zhang, Z Yang, J Trottier, O Barbier, L Wang Hepatology 65 (2), 604-615, 2017 | 171 | 2017 |
| Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus S Chen, D Beaton, N Nguyen, K Senekeo-Effenberger, ... Journal of Biological Chemistry 280 (45), 37547-37557, 2005 | 158 | 2005 |
| Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study J Trottier, A Białek, P Caron, RJ Straka, J Heathcote, P Milkiewicz, ... Digestive and Liver Disease 44 (4), 303-310, 2012 | 154 | 2012 |
| Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through … K Senekeo-Effenberger, S Chen, E Brace-Sinnokrak, JA Bonzo, MF Yueh, ... Drug metabolism and disposition 35 (3), 419-427, 2007 | 147 | 2007 |
| Characterization of UDP-glucuronosyltransferases active on steroid hormones DW Hum, A Bélanger, É Lévesque, O Barbier, M Beaulieu, C Albert, ... The Journal of steroid biochemistry and molecular biology 69 (1-6), 413-423, 1999 | 145 | 1999 |
| H19 promotes cholestatic liver fibrosis by preventing ZEB1‐mediated inhibition of epithelial cell adhesion molecule Y Song, C Liu, X Liu, J Trottier, M Beaudoin, LI Zhang, C Pope, G Peng, ... Hepatology 66 (4), 1183-1196, 2017 | 136 | 2017 |
| UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells S Chouinard, O Barbier, A Bélanger Journal of Biological Chemistry 282 (46), 33466-33474, 2007 | 126 | 2007 |
